Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Matija Marković"'
Autor:
Maro Dragičević, Ivica Premužić Meštrović, Matija Marković, Mario Stipinović, Ena Kurtić, Ivica Paulić, Tomislav Letilović
Publikováno v:
Acta Clinica Croatica, Vol 63., Iss Supplement 1, Pp 23-25 (2024)
The loss of a stent during percutaneous coronary intervention (PCI) is a rare complication of the procedure. Multiple manoeuvres for the stent extraction exist, using a small balloon being a common one (2). This case report demonstrates the loss of
Externí odkaz:
https://doaj.org/article/44a5a7ca6bc546d7bc56e59ac07e057b
Autor:
Ena Kurtić, Ivica Premužić Meštrović, Matija Marković, Vinko Roso, Valentina Obadić, Mario Stipinović, Tomislav Letilović
Publikováno v:
Acta Clinica Croatica, Vol 62., Iss 3, Pp 551-555 (2023)
Destructive thyroiditis is a self-limited disease characterized by acute release of preformed thyroid hormones. We present a patient with extremely rare acute painful thyroiditis after percutaneous coronary intervention (PCI) in acute myocardial in
Externí odkaz:
https://doaj.org/article/75fa121953d54c6e872a9406725a303f
Autor:
Laura Carla Kraljević, Matija Marković
Publikováno v:
Liječnički vjesnik, Vol 145, Iss Supp 2, Pp 72-72 (2023)
Left ventricular pseudoaneurysm is rare and life-threatening condition which can happen after untreated myocardial infarction, cardiac surgery, infection or trauma. It is formed when cardiac wall rupture is contained by adherent pericardium, scar tis
Externí odkaz:
https://doaj.org/article/60860b604f884ca28eaf9621d3d41b25
Autor:
Matija Marković
Publikováno v:
Zbornik radova Fakulteta tehničkih nauka u Novom Sadu. 37:869-872
fokus rada usmeren je na analizu inovativnog potencijala odabranih preduzeća, gde je , navedeno kakva je uloga inovacije i inovacionog potencijala u sklopu jednog poslovnog sistema.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13e87b121abed0d63f289d23c75c93b1
https://doi.org/10.24867/17gi02markovic
https://doi.org/10.24867/17gi02markovic
Autor:
Andrijana Kološa, Katarina Gorup, Matija Marković, Ena Kurtić, Maro Dragičević, Tomislav Letilović, Tomislav Meštrović, Ivica Premužić Meštrović
Publikováno v:
Cardiologia Croatica
Volume 17
Issue 9-10
Volume 17
Issue 9-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4ece553a432e0651af800f8a65e752e
https://doi.org/10.15836/ccar2022.177
https://doi.org/10.15836/ccar2022.177
Publikováno v:
Cardiologia Croatica
Volume 16
Issue 9-10
Volume 16
Issue 9-10
Cardiologists are familiar with valvular heart diseases but often they do not perceive heart valves as source of ventricular arrhythmias (VA). In patients with structural heart disease (SHD) VAs originate from a substrate in diseased myocardium, whil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afd95fad9841175be3f9ed0ce9074697
https://doi.org/10.15836/ccar2021.312
https://doi.org/10.15836/ccar2021.312
Introduction: Lidocaine is an essential drug used as a local anesthetic and as antiarrhythmic medication of the class Ib type. There are multiple reports in literature that lidocaine can cause coronary artery spasm both in vitro and in vivo1, 2. Elev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ccde1053b468e6ca35403d176e4e090
https://doi.org/10.15836/ccar2016.97
https://doi.org/10.15836/ccar2016.97
Autor:
Karlo Novačić, Ivica Premužić Meštrović, Gabrijela Perić Marković, Matija Marković, Ena Kurtić, Tomislav Meštrović
Publikováno v:
Cardiologia Croatica. 13:333-333
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::182b5c4d3f704993088c82e7583c83ef
https://doi.org/10.15836/ccar2018.333
https://doi.org/10.15836/ccar2018.333
Autor:
Ena Kurtić, Ivica Premužić Meštrović, Sofiya Andreykanich, Mario Stipinović, Matija Marković, Bojana Aćamović Stipinović, Helena Jerkić, Tomislav Letilović, Darko Počanić
Publikováno v:
Cardiologia Croatica. 13:342-342
Introduction: Implantation of implantable cardioverter defibrillator (ICD) as a primary prevention (PP) is indicated in patients with dilated cardiomyopathy (DCM) with a reduced ejection fraction as well as a life expectancy longer than a year. Impla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3da4e192f77e2627d523acb3ceb42772
https://doi.org/10.15836/ccar2018.342
https://doi.org/10.15836/ccar2018.342
Autor:
Darko Počanić, Mario Stipinović, Ivica Premužić Meštrović, Damir Kozmar, Darko Vujanić, Stjepan Kranjčević, Helena Jerkić, Tomislav Letilović, Maro Dragičević, Ena Kurtić, Matija Marković
Publikováno v:
Cardiologia Croatica. 13:338-338
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7ab7ee1c877fcf894323042bafd6a93
https://doi.org/10.15836/ccar2018.338
https://doi.org/10.15836/ccar2018.338